Translation capability for your selected language is limited for technical regulatory content. The English version is the authoritative reference.
FRESHNESS NOTICE
This publication was issued on 4 January 2026. This brief was generated on 10 April 2026. The IPOS source page was last updated on 10 April 2026, confirming the suspension remains in effect as at brief date. Practitioners should verify current programme status directly with IPOS before advising on acceleration options. Any time-sensitive provisions — including the grandfathering of pre-4 January 2026 requests — should be confirmed against current primary sources.
Classification Summary
Publication Type
Circular — Circular No. 1/2025 (Registry of Patents) and Circular No. 2/2025 (Registry of Trade Marks), updated to reflect suspension effective 4 January 2026
Primary Instruments
IPOS Circular No. 1/2025 — Registry of Patents
·
IPOS Circular No. 2/2025 — Registry of Trade Marks
·
Patents Forms 11 / 12 / 13A; Trade Marks Form TM4
Significance
MEDIUM — The suspension of both active acceleration programmes with effect from 4 January 2026, with no confirmed resumption date, materially alters available prosecution pathways for IP practitioners and filers in Singapore and requires immediate reassessment of acceleration strategy.
Brief Date
10 April 2026 — RegLegBrief
What Changed
The operative change is the suspension of acceptance of new acceleration requests under both the SG Patents Fast and SG Trade Marks Fast programmes from 4 January 2026 until further notice.
[Source: IPOS Circular, 4 January 2026 →]
IPOS has indicated that it is reviewing the programmes, but the circular provides no explanation of the grounds for review, no timetable for completion, and no indication of whether the programmes will be modified, replaced, or permanently discontinued upon conclusion of the review. The suspension is therefore of indefinite duration.
The two programmes were themselves relatively recent. IPOS launched
SG Patents Fast and SG Trade Marks Fast
on 20 May 2025, themselves replacing the SG IP FAST pilot programme that concluded on 31 December 2024.
[Source: IPOS Circular, 4 January 2026 →]
The current suspension therefore means that, as at 4 January 2026, no IPOS-native acceleration programme is accepting new requests. The acceleration architecture that has existed in successive forms since the SG IP FAST pilot has been placed entirely on hold pending the outcome of IPOS's review.
The grandfathering provision is clear in its scope. Requests filed before 4 January 2026 that meet the respective qualifying criteria will continue to be processed on the accelerated timelines.
[Source: IPOS Circular, 4 January 2026 →]
For SG Patents Fast, this means that accepted requests for first office actions under the four-month (Fast 4) or eight-month (Fast 8) tracks, and accepted requests for acceleration of subsequent office actions under
Patents Form 13A
,
will continue to be honoured. The monthly cap of five requests per entity that applied under SG Patents Fast does not apply to subsequent office action acceleration requests, and this distinction continues to apply to in-flight matters.
[Source: IPOS Circular, 4 January 2026 →]
For new acceleration requirements arising after 4 January 2026, the circular identifies two alternative pathways. For patents, the
Patent Prosecution Highway (PPH)
remains available as an international work-sharing mechanism. For trade marks, selecting descriptions from the IPOS pre-approved classification database continues to reduce examination time and attract lower official fees per class.
[Source: IPOS Circular, 4 January 2026 →]
Notably, PPH is contingent on having a corresponding application at a partner IP office with favourable examination results — a structural precondition that not all applicants will satisfy, particularly those with Singapore-first filing strategies or purely domestic prosecution matters.
The government support schemes applicable to acceleration costs — specifically, tax deductions under the
Enterprise Innovation Scheme (EIS)
and grant funding under the
Enterprise Development Grant (EDG)
— are referenced in the circular as applicable to the suspended programmes. The circular does not confirm whether these funding mechanisms extend to PPH-related costs or other alternative acceleration pathways; this is a material open question for enterprise filers and their advisers requiring direct confirmation from IPOS.
PRACTITIONER ALERT — FEE REFUND POSITION UNCONFIRMED
The circular is silent on whether acceleration fees paid for SG Patents Fast or SG Trade Marks Fast requests submitted before 4 January 2026, where those requests are now pending processing, are refundable or transferable in the event that IPOS's review results in programme discontinuation. Practitioners and enterprise filers with in-flight requests should seek direct written confirmation from IPOS at ipos_enquiry@ipos.gov.sg on the fee position for their specific matters before acting on assumptions of refundability or transfer.
Who Is Affected
The suspension directly affects any enterprise, innovator, or legal practitioner that was relying on IPOS-native acceleration programmes for new Singapore patent or trade mark applications filed on or after 4 January 2026. The practical scope is broad: the programmes had been designed with simplified eligibility criteria specifically to benefit a wide range of enterprises and innovators, and their suspension removes an accessible acceleration option that the previous pilot and successor programmes had maintained continuously since the SG IP FAST pilot launch.
Enterprise IP Portfolio Manager — high-volume Singapore prosecution pipeline
The five-per-entity monthly cap under SG Patents Fast had forced large enterprises and law firm IP teams to sequence and batch acceleration requests across calendar months — prioritising filings by urgency, commercial deadline, or claim count within the 20-claim limit. That sequencing discipline is now both unnecessary and unavailable: the suspension eliminates the cap and the programme simultaneously. For portfolio managers currently holding in-flight acceleration requests grandfathered under the pre-4 January 2026 cutoff, the immediate operational step is to conduct a forward-looking PPH eligibility audit across the pipeline — identifying which pending applications have, or will shortly have, a favourable examination result at a PPH partner office, and sequencing those for PPH requests to IPOS rather than waiting for programme reinstatement.
I manage a Singapore prosecution portfolio that was previously working within the five-per-entity monthly cap — what criteria are you using to prioritise which applications to route through PPH now that IPOS-native acceleration is suspended, and how are you communicating revised prosecution timelines to internal stakeholders?
Your views →
The impact is asymmetric across different practitioner and applicant profiles. Entities with access to favourable examination results from PPH partner offices face a meaningfully different landscape than those pursuing purely domestic prosecution or first-time Singapore filings without a corresponding foreign application at an eligible partner office. Trade mark applicants lose a fee-accessible fast-track but retain partial mitigation through pre-approved classification descriptions.
Primary
IP Prosecution Counsel and Patent Attorneys
Practitioners managing Singapore patent and trade mark prosecution portfolios must reassess acceleration strategy for matters where fast-track timelines were built into client commitments or freedom-to-operate timelines. For patent matters, PPH eligibility analysis is now a preliminary step for any client requiring acceleration. The monthly cap of five requests per entity under SG Patents Fast had been a planning constraint; its removal through suspension creates a different but more fundamental constraint — no IPOS-native path at all for new requests.
Primary
Technology Companies and Innovation-Driven Enterprises
Enterprises that had integrated SG Patents Fast or SG Trade Marks Fast into their Singapore IP strategy — including those utilising EIS tax deductions and EDG funding for acceleration costs — face both a procedural and potentially a financial planning disruption. The alignment between government support schemes and the suspended programmes requires re-examination, particularly for budget cycles that had anticipated acceleration fees as a qualifying cost category under EIS or EDG.
Secondary
Foreign Filers and Multinational IP Portfolio Managers
Foreign applicants who relied on the simplified eligibility criteria of SG Patents Fast — which, unlike the PPH, did not require a prior corresponding application at a partner office — must now assess whether their prosecution portfolio generates the necessary foreign examination results to utilise PPH. For purely Singapore-first filers or applicants whose foreign prosecution is at an early stage, no comparable IPOS-administered acceleration mechanism is presently available.
Cross-Border
PPH Partner Office Applicants
Applicants with corresponding applications at IPOS's PPH partner offices — who may have previously used SG Patents Fast as an alternative or complement to PPH — are now channelled exclusively toward the PPH route for acceleration. The practical implication is that PPH eligibility assessment, including verification that the partner office application has been found allowable, becomes a threshold step in any Singapore patent acceleration strategy for this cohort.
Directly Affected
SG Patents Fast (Fast 4 and Fast 8 tracks)
— Both tracks suspended for new requests from 4 January 2026. No IPOS-native patent acceleration available for new applications pending outcome of review.
SG Trade Marks Fast
— Suspended for new requests from 4 January 2026. The three-to-six-week first examination report timeline is no longer available for new applicants via this route.
Patents Forms 11 and 12
— Acceleration requests via these forms no longer accepted for new SG Patents Fast applications. Standard (non-accelerated) processing continues.
Trade Marks Form TM4
— Acceleration election at point of filing Form TM4 suspended. Standard Form TM4 applications continue unaffected; only the acceleration component is suspended.
Potentially Affected
Enterprise Innovation Scheme (EIS) — tax deduction for acceleration fees
— The EIS deduction was explicitly linked to IP acceleration fees under the suspended programmes. Whether EIS coverage extends to PPH costs or other alternative pathways requires confirmation; the circular does not address this.
Enterprise Development Grant (EDG) — IP registration and acceleration costs
— EDG coverage of acceleration fees was referenced in the context of the suspended programmes. Applicability to PPH costs is not confirmed in the circular and should be verified with EDG administrators.
Patents Form 13A — subsequent office action acceleration
— In-flight SG Patents Fast matters remain eligible for Form 13A subsequent office action acceleration. The position for new Form 13A requests where the original Fast application was filed before 4 January 2026 is covered by the grandfathering provision.
Future IPOS acceleration programme — inference: IPOS's statement that it "is reviewing the programmes" implies a successor or modified programme may emerge. The scope, eligibility criteria, and fee structure of any successor instrument are entirely unconfirmed. Practitioners should monitor IPOS communications for any consultation or announcement.
Monitor for Updates
Patent Prosecution Highway (PPH) — IPOS partner network
— Currently the primary available patent acceleration route. Monitor for any changes to IPOS's PPH partner office network or procedural requirements as volumes potentially increase following the SG Patents Fast suspension.
IPOS review outcome — The circular confirms IPOS "is reviewing the programmes" but provides no timetable. The review outcome could result in programme reinstatement, modification, replacement, or permanent discontinuation. Monitor IPOS official communications and the circular source page (last updated 10 April 2026) for updates.
SG IP FAST pilot programme (concluded 31 December 2024)
— Historical predecessor. IPOS's pattern of successive programme iterations (SG IP FAST → SG Patents/Trade Marks Fast) suggests a redesigned successor is likely; programme structure of any successor instrument is unconfirmed.
Trade mark classification practice — selecting descriptions from IPOS pre-approved classification database remains available as an informal acceleration mechanism and attracts lower official fees per class. Monitor for any IPOS guidance on expanded pre-approved descriptions as a response to the suspension.
Key Dates
| Event |
Date / Status |
Action Required |
| SG Patents Fast and SG Trade Marks Fast launched — superseding SG IP FAST pilot |
20 May 2025 |
Reference only — programmes now suspended for new requests |
| Suspension of new acceleration requests — SG Patents Fast and SG Trade Marks Fast |
Confirmed 4 January 2026 |
No new acceleration requests accepted under either programme from this date. Practitioners with pending new matters must assess alternative pathways (PPH for patents; pre-approved classification descriptions for trade marks) |
| Grandfathered pre-4 January 2026 requests — continued processing on accelerated timelines |
Immediate Ongoing from 4 January 2026 |
In-flight requests filed before 4 January 2026 that meet qualifying criteria continue on original timelines. Confirm eligibility status of each in-flight matter. Seek written confirmation from IPOS on fee position for pending requests |
| Resumption of programme or announcement of successor / replacement |
Pending No date confirmed |
Monitor IPOS official communications. No timetable has been provided. SOURCE_CONTENT page last updated 10 April 2026 confirms suspension remains in effect at brief date |
| Fee refund / transfer position for in-flight acceleration requests |
Pending Not addressed in circular |
SOURCE_CONTENT is silent on refundability or transferability of acceleration fees. Direct enquiry to ipos_enquiry@ipos.gov.sg recommended for affected filers before making assumptions on fee recovery |
Regulatory Trajectory
Enforcement Direction
→
Stable — No Enforcement Dimension
The suspension is an administrative and procedural measure affecting examination timelines, not an enforcement action; no enforcement trend inference is warranted from this publication.
Rulemaking Pipeline
→
Pending — Review Outcome Awaited
IPOS has confirmed a programme review is underway but has disclosed no timetable, consultation process, or indication of the review's scope; a successor or modified framework may emerge but remains entirely unconfirmed.
International Alignment
→
Monitoring — PPH Framework Maintained
Singapore's participation in the Patent Prosecution Highway network with global IP office partners remains unaffected; IPOS's international acceleration commitments through the PPH framework continue while the domestic programme is under review.
Impact Analysis
The indefinite suspension of SG Patents Fast and SG Trade Marks Fast removes the primary IPOS-administered acceleration mechanism from the Singapore prosecution toolkit effective 4 January 2026. For practitioners and applicants who had integrated these programmes into standard prosecution workflows, the immediate operational consequence is a structural gap between the acceleration options that existed from May 2025 and those presently available. The analytical significance lies not in what the circular says, but in the duration of silence on the review's scope and timeline.
Filing Strategy Implications for Patent Prosecution
With SG Patents Fast suspended, the Patent Prosecution Highway is the only available IPOS-recognised acceleration mechanism for new patent applications. The structural difference between the two mechanisms is material: SG Patents Fast was available on the basis of the Singapore application itself, subject only to claim count (20 or fewer) and non-divisional status, with no requirement for a corresponding foreign application. The PPH is inherently predicated on a corresponding application at a partner office having been found allowable or having received a favourable written opinion. For applicants with Singapore-first strategies — including local innovators and SMEs without parallel PCT or foreign national phase applications — the PPH route is not available as a simple substitution. This is an inference grounded in the SOURCE_CONTENT description of PPH as referencing "examination results from another IP office," in contrast to SG Patents Fast's eligibility criteria which contained no such requirement.
IP Prosecution Partner — Singapore filing strategy perspective
The PPH is not a direct substitute for SG Patents Fast for a significant class of applicants. Clients with purely domestic Singapore applications, or with foreign applications still at early prosecution stages, lack the "allowable claim" foundation that PPH requires. Practitioners advising innovation-stage companies should explicitly assess PPH eligibility before communicating any acceleration expectation — and should identify at briefing stage whether the client has or intends to file at a PPH partner office on a timeline compatible with Singapore prosecution needs.
I am advising a client with a Singapore-first filing and no foreign application yet at a PPH partner office — what has your practice been in this gap between SG Patents Fast and PPH eligibility, and what are you telling clients about realistic prosecution timelines in the interim?
Your views →
Trade Mark Acceleration — Partial Mitigation Available
The trade mark position is more nuanced. SG Trade Marks Fast had offered a three-to-six-week timeline for first examination report delivery, available without the prerequisite of a related patent application or full adoption of pre-approved IPOS classification descriptions. The suspension eliminates that fee-accessible fast-track for new applications. However, the circular notes that selecting descriptions from the IPOS pre-approved classification database continues to reduce examination time and attract lower official fees per class. This is not a controlled acceleration programme with guaranteed timelines — it is an informal processing benefit derived from examiner efficiency in reviewing pre-approved descriptions. Practitioners advising on trade mark filings where speed is material should reframe client expectations: the pre-approved classification pathway offers relative, not guaranteed, processing advantage, and the differential from standard examination is not quantified in the circular.
Trade Mark Practitioner — multi-class Singapore applications filed before 4 January 2026
The SG Trade Marks Fast qualifying criteria stipulated that for multi-class applications, the acceleration request automatically applied to all classes — there was no option to accelerate selected classes while leaving others on standard timelines. For in-flight multi-class trade mark applications filed before 4 January 2026 and grandfathered under the suspension, this means the accelerated examination timeline applies to every class in the application, not just those the practitioner may have considered most time-critical. Practitioners managing these in-flight matters should confirm with IPOS the expected examination timeline for each class and ensure that client instructions and goods/services descriptions for all classes are in order — since the automatic multi-class acceleration means objections across all classes may arrive on the same compressed timeline.
I have in-flight multi-class trade mark applications accepted for SG Trade Marks Fast before 4 January 2026 — are you finding that IPOS is issuing examination reports across all classes simultaneously or staggering them, and how are you preparing clients for potential simultaneous objections across multiple classes?
Your views →
Government Funding Schemes — Unresolved Applicability
The circular's reference to EIS and EDG coverage of acceleration fees was made in the context of the programmes now suspended. Whether EIS tax deductions and EDG grant funding apply to acceleration costs incurred through alternative pathways — specifically PPH filing and processing costs — is not addressed in the source document. For enterprise clients managing IP cost strategy under these government schemes, the absence of confirmation creates a material planning uncertainty. As an inference, EIS and EDG scheme eligibility is typically assessed against qualifying expenditure definitions set by the relevant administering agencies (Enterprise Singapore in the case of EDG) rather than IPOS directly; confirmation should therefore be sought from those agencies in addition to IPOS. Practitioners should not assume continuity of funding eligibility in the absence of express confirmation.
Duration Risk — Indefinite Suspension Without Review Timetable
The most significant analytical uncertainty is the absence of any indication of review timeline or scope. The suspension is expressed as effective "until further notice," with no minimum or maximum review period, no indication of whether industry consultation will be undertaken, and no guidance on whether the programmes will be modified or replaced. For practitioners managing multi-year prosecution portfolios or advising on IP strategy for product launches with defined market-entry timelines, this uncertainty is operationally significant. The pattern of programme evolution — SG IP FAST pilot concluding December 2024, succeeded by SG Patents Fast and SG Trade Marks Fast in May 2025, now suspended seven months later — does suggest active programme design iteration by IPOS, and a successor instrument is a reasonable inference, but its terms, timeline, and eligibility structure are entirely unconfirmed.
In-Flight Matters — Grandfathering and Fee Position
The grandfathering provision for pre-4 January 2026 requests is clearly stated and provides continuity for accepted acceleration requests. The material gap in the circular is the fee position. The circular does not address whether acceleration fees paid in connection with in-flight requests — particularly where those requests are still awaiting processing — are recoverable in the event that the review results in programme discontinuation or structural modification that affects their processing. This is not a hypothetical concern: practitioners holding accepted acceleration requests should, as a precautionary step, seek written confirmation from IPOS of the fee position for their specific matters. The enquiry address given in the source is ipos_enquiry@ipos.gov.sg.
Active Parallel Review
🇸🇬 Singapore — IPOS review of SG Patents Fast and SG Trade Marks Fast programmes underway; no timetable or scope disclosed. Source page updated 10 April 2026 confirms suspension remains in effect.
🌐 PPH Network (Global) — Patent Prosecution Highway remains the active international acceleration alternative available to IPOS applicants; partner office network and bilateral PPH agreements continue unaffected by the domestic suspension.
🇸🇬 Singapore — Government support scheme eligibility (EIS, EDG) for alternative acceleration costs: unresolved question pending IPOS and Enterprise Singapore clarification.
Expected to Follow
🇸🇬 Singapore — IPOS successor or modified acceleration programme: a reasonable inference from the review process and the pattern of programme iteration since SG IP FAST, but entirely unconfirmed. Monitor IPOS for any consultation notice or announcement.
🇬🇧 United Kingdom — IPO operates its own fast-track examination services (e.g. Combined Search and Examination, accelerated processing requests); not directly affected by IPOS suspension but relevant for cross-jurisdictional filers benchmarking alternatives. Contextual reference only — not source-verified for this brief.
🇪🇺 European Union — EPO accelerated prosecution (PACE programme) continues independently; filers with EP applications may utilise PACE results in combination with IPOS PPH. Not directly affected by IPOS suspension.
No Current Action
🇺🇸 United States — USPTO Track One prioritised examination and PPH programmes continue independently; no direct impact from IPOS suspension. USPTO examination results remain eligible for IPOS PPH requests.
🇯🇵 Japan — JPO Super Accelerated Examination and PPH programmes continue independently; JPO is a key IPOS PPH partner office. No direct impact.
🇰🇷 Republic of Korea — KIPO fast-track programmes continue independently; KIPO is an IPOS PPH partner office. No direct impact from IPOS domestic suspension.
🇨🇳 China — CNIPA accelerated examination programmes continue independently. China is a significant jurisdiction for Singapore-based filers with parallel prosecution strategies. No direct impact from IPOS suspension.
Reading this brief on a free account?
Try 7 days of full access — no card required.
Start free trial →
Confidence & Source Record
Source
S1
Intellectual Property Office of Singapore — Circular: New Patents and Trade Marks Acceleration Programmes (Circular No. 1/2025 — Registry of Patents; Circular No. 2/2025 — Registry of Trade Marks), 4 January 2026 —
ipos.gov.sg →
Language
L1
English — full analytical capability
Verification
V1
Verified from ipos.gov.sg on 4 January 2026. Source page last updated 10 April 2026.
Analysis
A2
Interpretive analysis — our rigorous, multi-dimensional methodology applied to analyse this regulatory update.
Jurisdiction
J1
Singapore — Tier 1 major financial and IP centre
Aging
CR
Brief-verified — 10 April 2026. Next review: triggered by regulatory update or reader flag.
Political Risk
P0
Stable jurisdiction
Community
U3
Viewed — insights welcome
Share your perspective on this brief.
Quality insights are recognised and surfaced to a community of senior legal and compliance professionals.
Share your insight →
Regulatory Body
Intellectual Property Office of Singapore (IPOS)
IPOS is the statutory body under Singapore's Ministry of Law responsible for administering the Registries of Patents, Trade Marks, Registered Designs, and Geographical Indications, and for advising the Government on IP policy.
S1·L1
Actions
Subscribe
Daily Alerts
Receive briefs for your jurisdictions and practice areas. Free. Set your preferences once.
Subscribe free →
Learning Hub
Learning Hub
Structured pathways for practitioners building depth in this regulatory area, including professional certification preparation.
Explore →
Launching soon
Corporate Access
For Legal & Compliance Teams
Ad-free for your team. Personalised alerts by jurisdiction and practice area. Try free for 7 days.
Start free trial →
Collaborate
Place Your Expertise Here
Place your expertise alongside this brief to help practitioners navigate the implications.
See how it works →
Share Your Insights
Share Your Insights
Practitioner perspectives and professional observations on this topic are welcomed. Quality contributions are recognised and surfaced across the platform.
Share →
Suggest a Correction
Submit a Comment
Noticed something that warrants updating? Help us maintain accuracy across 210 jurisdictions. Confirmed contributions are credited to you.
Submit →
Save
Save to Your Reading List
Save this brief to your RegLegBrief reading list — accessible from any device when you are signed in.
Save this brief →
Independent Practitioners
For Independent Practitioners & Boutique Firms
Build your presence in the regulatory intelligence community. Contributor recognition, expert tagging and professional visibility — without the overhead of a large firm.
Join as a contributor →
Disclaimer
This brief is produced by the RegLegBrief Publication Engine and is intended for senior legal and compliance professionals. It does not constitute legal advice. Every factual claim is sourced from the primary regulatory publication identified in the source record and professional analytical inferences are labelled as such. For matter-specific application, the primary sources should be verified and professional advice obtained. This brief was verified from the Intellectual Property Office of Singapore's official domain (ipos.gov.sg) on 10 April 2026. Singapore is assessed as a stable jurisdiction (P0) with no current political or operational disruption affecting the validity or operational status of instruments cited in this brief. Where contextual references are made to parallel frameworks in other jurisdictions, these are contextual and have not been independently verified against those jurisdictions' primary sources for the purposes of this brief.